Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Synovial 1Sarcoma 1Rhabdomyosarcoma 1Neurofibrosarcoma 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Fibrosarcoma 1

Interventions

Doxorubicin 9Ifosfamide 8Radiotherapy 6Neoadjuvant Therapy 3Chemotherapy, Adjuvant 3Trabectedin 2Filgrastim 2Etoposide 2pembrolizumab 1pegfilgrastim 1olaratumab 1milademetan 1indolepropanol phosphate 1brigimadlin 1X-Rays 1Watchful Waiting 1Vincristine 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy, Conformal 1Observation 1Epirubicin 1Diathermy 1Dactinomycin 1Dacarbazine 1Cyproheptadine 1Cyclophosphamide 1Combined Modality Therapy 1Carboplatin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Liposarcoma × Combined Modality Therapy × Clear all
NCT00061984 2014-10-27

Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
455 enrolled
Sarcoma

Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡